Bone Marrow Transplant Patients
| UPN . | A/S . | aGvHD . | cGvHD . | CMV . | MNC ×108/kg . | CFU-GM ×104/kg . |
|---|---|---|---|---|---|---|
| 1 | 24/M | 2 | 1 | − | 3.2 | |
| 42 | 15/F | 0 | 0 | − | 10.4 | |
| 52 | 23/M | 2 | 3 | NE | 2.5 | |
| 73 | 7/F | 2 | 1 | − | 4.2 | |
| 91-150 | 22/F | 0 | 0 | − | 2 | |
| 100 | 21/M | 3 | 3 | − | 2.3 | |
| 194 | 9/M | 1 | 0 | − | 2.3 | |
| 324 | 21/F | 1 | 0 | − | 4.3 | |
| 373 | 28/F | 1 | 1 | + | 3.3 | |
| 450 | 26/M | 2 | 3 | − | 2 | |
| 455 | 18/M | 3 | 3 | + | 4.6 | |
| 462 | 14/F | 1 | 1 | − | 3.3 | 3.8 |
| 555 | 36/F | 1 | 1 | − | 4 | |
| 587 | 12/M | 2 | 3 | + | 2.3 | |
| 608 | 34/M | 1 | 1 | − | 3.3 | 5.5 |
| 626 | 20/M | 1 | 1 | − | 3.4 | |
| 638-150 | 19/F | 0 | 0 | + | 5.6 | 6 |
| 639 | 32/M | 2 | 3 | − | 5.6 | 7.6 |
| 657 | 16/M | 0 | 0 | − | 4.1 | 8.5 |
| 682 | 18/F | 0 | 0 | − | 6.1 | |
| 741 | 21/M | 1 | 1 | − | 5.7 | 5.5 |
| 744 | 18/M | 1 | 1 | − | 2.5 | 2.4 |
| 753 | 29/M | 2 | 1 | − | 7.5 | 6.7 |
| 755 | 16/F | 1 | 0 | − | 3.8 | 6.2 |
| 760 | 31/M | 1 | 3 | − | 5.4 | 4.5 |
| 811 | 30/M | 2 | 3 | − | 6 | 24.0 |
| 825 | 21/M | 1 | 1 | + | 7.9 | 3.6 |
| 875 | 23/M | 1 | 1 | − | 6 | 6.6 |
| Median | 21 | 4.1 | 6 | |||
| Range | 7-36 | 2-10.4 | 2.4-24.0 |
| UPN . | A/S . | aGvHD . | cGvHD . | CMV . | MNC ×108/kg . | CFU-GM ×104/kg . |
|---|---|---|---|---|---|---|
| 1 | 24/M | 2 | 1 | − | 3.2 | |
| 42 | 15/F | 0 | 0 | − | 10.4 | |
| 52 | 23/M | 2 | 3 | NE | 2.5 | |
| 73 | 7/F | 2 | 1 | − | 4.2 | |
| 91-150 | 22/F | 0 | 0 | − | 2 | |
| 100 | 21/M | 3 | 3 | − | 2.3 | |
| 194 | 9/M | 1 | 0 | − | 2.3 | |
| 324 | 21/F | 1 | 0 | − | 4.3 | |
| 373 | 28/F | 1 | 1 | + | 3.3 | |
| 450 | 26/M | 2 | 3 | − | 2 | |
| 455 | 18/M | 3 | 3 | + | 4.6 | |
| 462 | 14/F | 1 | 1 | − | 3.3 | 3.8 |
| 555 | 36/F | 1 | 1 | − | 4 | |
| 587 | 12/M | 2 | 3 | + | 2.3 | |
| 608 | 34/M | 1 | 1 | − | 3.3 | 5.5 |
| 626 | 20/M | 1 | 1 | − | 3.4 | |
| 638-150 | 19/F | 0 | 0 | + | 5.6 | 6 |
| 639 | 32/M | 2 | 3 | − | 5.6 | 7.6 |
| 657 | 16/M | 0 | 0 | − | 4.1 | 8.5 |
| 682 | 18/F | 0 | 0 | − | 6.1 | |
| 741 | 21/M | 1 | 1 | − | 5.7 | 5.5 |
| 744 | 18/M | 1 | 1 | − | 2.5 | 2.4 |
| 753 | 29/M | 2 | 1 | − | 7.5 | 6.7 |
| 755 | 16/F | 1 | 0 | − | 3.8 | 6.2 |
| 760 | 31/M | 1 | 3 | − | 5.4 | 4.5 |
| 811 | 30/M | 2 | 3 | − | 6 | 24.0 |
| 825 | 21/M | 1 | 1 | + | 7.9 | 3.6 |
| 875 | 23/M | 1 | 1 | − | 6 | 6.6 |
| Median | 21 | 4.1 | 6 | |||
| Range | 7-36 | 2-10.4 | 2.4-24.0 |
Abbreviations: UPN, unique patient number; A/S, age/sex; aGvHD, acute graft-versus-host disease; cGvHD, chronic graft-versus-host disease; CMV, cytomegalovirus; MNC, mononuclear cells infused; CFU-GM, colony forming unit-granulocyte machrophages infused.
Twins.